Specifications
| SKU | ISG007376 |
| Brand | Uricodrop |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 80 Mg |
| Shop by Concerns | Gout |
| Gender | Neutral |
| Shop By Goals | Gout Management |
| Imported Or Local | Local |
| Ingredient | Febuxostat |
| UPC | 6223003571405 |
| Product Form | Tablets |
| Specialty | Clinically Tested Prescription only |
| Sub Categories | Gout Medicines |
| Unit Count | 30 Tablets |
| Warning | Keep Out of Reach of Children cardiovascular risk Caution in Liver or Kidney Impairment Not for acute conditions Use under medical supervision only |
About the product›
Uricodrop 80 Mg 30 Tablets
Description:
Uricodrop 80 mg 30 tablets is a prescription oral medicine containing febuxostat, a xanthine oxidase inhibitor used to lower high uric acid levels in the blood. It is specifically indicated for the long‑term management of chronic hyperuricaemia in patients with gout where urate crystal deposition has already occurred, helping to prevent gout attacks, joint pain, and uric acid crystal complications. Manufactured by Marcyrl Pharmaceutical Industries (MPI), Uricodrop is formulated as film‑coated tablets for once‑daily dosing under medical supervision.
Indications:
- Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (including a history or presence of gouty arthritis and/or tophus).
- Long‑term management of elevated serum uric acid levels in adult patients with gout.
- Helps reduce the risk of recurrent gout flares, joint swelling, redness, and pain associated with high uric acid.
- Prevention of further urate crystal deposition in joints and soft tissues when used regularly as prescribed.
Active Ingredients / Key Components:
- Febuxostat – 80 mg per film‑coated tablet.
- Excipients: Film‑coating and tablet core excipients (such as fillers, binders, disintegrants, and colorants) are present; the exact excipient list and their concentrations , please check the product leaflet or the manufacturer’s official website. Please refer to the official package leaflet for full details.
Dosage & Administration / How to Use:
- Standard adult dose: 1 tablet of Uricodrop 80 mg once daily, or as directed by your physician.
- Swallow the tablet whole with a glass of water; do not crush or chew.
- Can be taken with or without food; try to take it at the same time each day for best effect.
- Uricodrop is intended for long‑term treatment; do not stop taking it without consulting your doctor, even if symptoms improve.
- Your doctor may monitor serum uric acid levels and adjust treatment as needed.
- If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
- Use only in adults and only under medical supervision. Not recommended for use in children and adolescents unless specifically prescribed by a specialist.
Clinical Benefits:
- Effectively lowers serum uric acid levels by inhibiting xanthine oxidase, the enzyme responsible for uric acid production.
- Helps prevent recurrent gout attacks, reducing episodes of intense joint pain, swelling, and redness.
- Supports long‑term protection of joints and soft tissues by limiting further urate crystal deposition.
- Once‑daily dosing improves treatment adherence and simplifies chronic gout management.
Warnings & Contraindications:
- Use only under the supervision of a healthcare professional experienced in the management of hyperuricaemia and gout.
- Contraindicated in patients with known hypersensitivity to febuxostat or any component of the formulation.
- Not recommended in patients receiving azathioprine, mercaptopurine, or theophylline, due to potential serious interactions; consult your doctor for alternatives.
- Use with caution in patients with a history of major cardiovascular disease (such as heart attack or stroke); discuss risks and benefits with your physician.
- Use with caution in patients with kidney or liver impairment; dose adjustment or close monitoring may be required.
- Acute gout flares may still occur at the start of therapy as uric acid levels change; your doctor may prescribe additional medicines (e.g. NSAIDs or colchicine) to prevent or manage flares.
- Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; safety data in pregnancy and lactation are limited.
- Inform your doctor about all other medicines and supplements you are taking to avoid potential interactions.
- Not intended to treat acute gout attacks; it is for long‑term uric acid control.
- Keep out of reach of children.
Side Effects:
- Common side effects may include headache, nausea, mild gastrointestinal discomfort, diarrhea, or rash.
- Some patients may experience gout flares, especially during initial months of therapy.
- Less common but serious side effects can include severe skin reactions, liver function abnormalities, or cardiovascular events. Seek immediate medical attention if you experience chest pain, shortness of breath, severe rash, swelling of the face or tongue, or signs of allergic reaction.
- If any side effects are severe, persistent, or concerning, stop using the product and consult your healthcare provider promptly.
Storage Instructions:
Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children.
Specifications:
- Active ingredient: febuxostat 80 mg per film‑coated tablet.
- Form: film‑coated oral tablets.
- Pack size: 30 tablets per pack.
- Intended use: prescription medicine for adult gout and hyperuricaemia management.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.
